基于奈米技术的药物传输市场- 按技术（奈米晶体、奈米颗粒、脂质体、胶束）、应用（神经学、肿瘤学、心血管/生理学、抗发炎/免疫学、抗感染）、全球预测，2023 - 2032

2023 年至 2032 年，全球基于奈米技术的药物传输市场规模预计复合年增长率将超过 12.5%。越来越多的研究活动探索基于奈米颗粒的口服药物递送系统，以提高药物溶解度和生物利用度，正在彻底改变水溶性差的药物的递送。近年来，人们非常关注有效、安全和商业上可行的药物传输平台的开发。生物技术和奈米医学领域多功能奈米载体平台的不断进步也将有助于市场的成长。

整个基于奈米技术的药物传输产业根据技术、应用和区域进行细分。

就技术而言，2023年至2032年奈米晶体领域的市场规模可能会出现可观的复合年增长率。这种增长可归因于奈米晶体在提高多种药物的溶解度和生物利用度方面的潜力不断增加，特别是水溶性差的化合物。奈米晶体还显着增加了溶解所需的表面积，以增强药物溶解度，同时透过最小的聚集和降解提供稳定的药物製剂。

在应用方面，神经病学领域基于奈米技术的药物传输市场将扩大到2032年。奈米材料和奈米粒子提供的独特性能有助于药物跨血脑屏障（BBB）以及特定区域的精确输送大脑内。最近，奈米颗粒也被设计用于促进神经保护剂和溶栓药物，以限制中风期间和之后的脑损伤。为此，全球神经系统疾病和病症负担的增加将促进该细分市场的成长。

从地区来看，预计到2032 年，亚太地区基于奈米技术的药物输送产业规模将显着成长。这是由于投资、政府资助、学术研究以及与中国、日本、韩国和其他国家製药公司的合作不断增加。印度。癌症负担的不断增加也推动了对奈米技术的需求，将化疗药物直接输送到肿瘤部位，限制全身副作用并提高治疗效果。根据美国国立卫生研究院的数据，预计 2022 年印度癌症病例数将达到 14,61,427 例。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：基于奈米技术的药物传输产业见解

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 慢性病盛行率不断上升
    • 对个人化药物的偏好日益增加
    • 奈米材料的不断进步
  • 产业陷阱与挑战
    • 严格的监理政策
    • 奈米药物传输技术成本高
• 成长潜力分析
  • 依技术
  • 按申请
• COVID-19 影响分析
• 监管环境
• 近期进展及未来展望
• FDA 批准的基于奈米技术的产品和临床试验
• 波特的分析
• PESTEL分析

第 4 章：竞争格局，2022 年

• 介绍
• 2022 年公司矩阵分析
• 公司定位矩阵
• 主要市场参与者的竞争分析
• 策略仪表板，2022 年

第 5 章：基于奈米技术的药物传输市场规模和预测：按技术分类

• 按技术分類的主要趋势
• 奈米晶体
• 奈米粒子
• 脂质体
• 胶束
• 其他技术

第 6 章：基于奈米技术的药物传输市场规模与预测：按应用

• 按应用分類的主要趋势
• 神经病学
• 肿瘤学
• 心血管/生理学
• 抗发炎/免疫学
• 抗感染
• 其他应用

第 7 章：基于奈米技术的药物传输市场规模与预测：按地区

• 按地区分類的主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 8 章：公司简介

• AbbVie Inc.
• BlueWillow Biologics
• Camurus AB
• Celgene, Inc.
• Cristal Therapeutics
• Johnson and Johnson
• Merck and Co., Inc
• Nanobiotix
• NanoCarrier Co. Ltd.
• NanOlogy LLC
• Novartis International AG
• Starpharma Holdings Limited

Global nanotechnology-based drug delivery market size is poised to record over 12.5% CAGR from 2023-2032. The rising number of research activities for exploring nanoparticle-based oral drug delivery systems to offer improved drug solubility and bioavailability is revolutionizing the delivery of poorly water-soluble drugs. In recent years, there has been significant focus on the development of effective, safe, and commercially viable drug delivery platforms. The increasing advances in versatile nanocarrier platforms within the biotechnology and nanomedicine space will also contribute to the market growth.

The overall nanotechnology-based drug delivery industry is segmented based on technology, application, and region.

In terms of technology, the market size from the nanocrystals segment may record appreciable CAGR from 2023-2032. The growth can be attributed to the rising potential of nanocrystals in improving the solubility and bioavailability of wide range of drugs, especially in poorly water-soluble compounds. Nanocrystals also significantly augment the surface area needed for dissolution to render enhanced drug solubility whilst providing stable drug formulations via minimal aggregation and degradation.

With respect to application, the nanotechnology-based drug delivery market from the neurology segment will expand up to 2032. The unique properties offered by nanomaterials and nanoparticles help in the precise delivery of drugs across blood-brain barrier (BBB) as well as specific regions within the brain. Lately, nanoparticles are also engineered to facilitate neuroprotective agents and clot-dissolving drugs to limit brain damage during and after strokes. To that end, the rising burden of neurological disorders and conditions worldwide will add to the segment growth.

Regionally, APAC nanotechnology-based drug delivery industry size is projected to observe notable growth rate through 2032. This is due to the rising investments, government funding, academic research, as well as collaborations with pharmaceutical companies in China, Japan, South Korea, and India. The growing burden of cancer is also driving the need for nanotechnology in delivering chemotherapy drugs directly to tumor sites, limiting systemic side effects and enhancing the treatment outcomes. As per the National Institutes for Health, the estimated number of cancer cases in India reached 14,61,427 in 2022.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global nanotechnology-based drug delivery market 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Technology trends
  • 2.1.4 Application trends

Chapter 3 Nanotechnology-based Drug Delivery Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic conditions
    • 3.2.1.2 Increasing preference for personalized medicines
    • 3.2.1.3 Increasing advancements in nanomaterials
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory policies
    • 3.2.2.2 High cost of nanotechnology drug delivery technique
• 3.3 Growth potential analysis
  • 3.3.1 By technology
  • 3.3.2 By application
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Recent advancement and future prospects
• 3.7 FDA-approved nanotechnology-based products and clinical trials
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company positioning matrix
• 4.4 Competitive analysis of major market players
• 4.5 Strategy dashboard, 2022

Chapter 5 Nanotechnology-based Drug Delivery Market Size and Forecast, By Technology (USD Million)

• 5.1 Key trends, by technology
• 5.2 Nanocrystals
• 5.3 Nanoparticles
• 5.4 Liposomes
• 5.5 Micelles
• 5.6 Other technologies

Chapter 6 Nanotechnology-based Drug Delivery Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Neurology
• 6.3 Oncology
• 6.4 Cardiovascular/Physiology
• 6.5 Anti-inflammatory/Immunology
• 6.6 Anti-infective
• 6.7 Other applications

Chapter 7 Nanotechnology-based Drug Delivery Market Size and Forecast, By Region (USD Million)

• 7.1 Key trends, by region
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East & Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 Rest of Middle East & Africa

Chapter 8 Company Profiles

• 8.1 AbbVie Inc.
• 8.2 BlueWillow Biologics
• 8.3 Camurus AB
• 8.4 Celgene, Inc.
• 8.5 Cristal Therapeutics
• 8.6 Johnson and Johnson
• 8.7 Merck and Co., Inc
• 8.8 Nanobiotix
• 8.9 NanoCarrier Co. Ltd.
• 8.10 NanOlogy LLC
• 8.11 Novartis International AG
• 8.12 Starpharma Holdings Limited

Data Tables

• TABLE 1 Market revenue, by technology (2022)
• TABLE 2 Market share, by application (2022)
• TABLE 3 Market share, by region (2022)
• TABLE 4 Global nanotechnology-based drug delivery market size, by region, 2018-2022 (USD Million)
• TABLE 5 Global nanotechnology-based drug delivery market size, by region, 2023-2032 (USD Million)
• TABLE 6 Global nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 7 Global nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 8 Global nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 9 Global nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 10 Industry impact forces
• TABLE 11 Nanocrystals market size, 2018-2022 (USD Million)
• TABLE 12 Nanocrystals market size, 2023-2032 (USD Million)
• TABLE 13 Nanoparticles market size, 2018-2022 (USD Million)
• TABLE 14 Nanoparticles market size, 2023-2032 (USD Million)
• TABLE 15 Liposomes market size, 2018-2022 (USD Million)
• TABLE 16 Liposomes market size, 2023-2032 (USD Million)
• TABLE 17 Micelles market size, 2018-2022 (USD Million)
• TABLE 18 Micelles market size, 2023-2032 (USD Million)
• TABLE 19 Other technologies market size, 2018-2022 (USD Million)
• TABLE 20 Other technologies market size, 2023-2032 (USD Million)
• TABLE 21 Neurology market size, 2018-2022 (USD Million)
• TABLE 22 Neurology market size, 2023-2032 (USD Million)
• TABLE 23 Oncology market size, 2018-2022 (USD Million)
• TABLE 24 Oncology market size, 2023-2032 (USD Million)
• TABLE 25 Cardiovascular/physiology market size, 2018-2022 (USD Million)
• TABLE 26 Cardiovascular/physiology market size, 2023-2032 (USD Million)
• TABLE 27 Anti-inflammatory/immunology market size, 2018-2022 (USD Million)
• TABLE 28 Anti-inflammatory/immunology market size, 2023-2032 (USD Million)
• TABLE 29 Anti-infective market size, 2018-2022 (USD Million)
• TABLE 30 Anti-infective market size, 2023-2032 (USD Million)
• TABLE 31 Other applications market size, 2018-2022 (USD Million)
• TABLE 32 Other applications market size, 2023-2032 (USD Million)
• TABLE 33 North America nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 34 North America nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 35 North America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 36 North America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 37 North America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 38 North America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 39 U.S. nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 40 U.S. nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 41 U.S. nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 42 U.S. nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 43 Canada nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 44 Canada nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 45 Canada nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 46 Canada nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 47 Europe nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 48 Europe nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 49 Europe nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 50 Europe nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 51 Europe nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 52 Europe nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 53 Germany nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 54 Germany nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 55 Germany nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 56 Germany nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 57 UK nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 58 UK nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 59 UK nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 60 UK nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 61 France nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 62 France nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 63 France nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 64 France nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 65 Spain nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 66 Spain nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 67 Spain nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 68 Spain nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 69 Italy nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 70 Italy nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 71 Italy nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 72 Italy nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 73 Rest of Europe nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 74 Rest of Europe nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 75 Rest of Europe nanotechnology-based drug delivery market size, application, 2018-2022 (USD Million)
• TABLE 76 Rest of Europe nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 77 Asia Pacific nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 78 Asia Pacific nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 79 Asia Pacific nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 80 Asia Pacific nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 81 Asia Pacific nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 82 Asia Pacific nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 83 Japan nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 84 Japan nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 85 Japan nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 86 Japan nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 87 China nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 88 China nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 89 China nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 90 China nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 91 India nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 92 India nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 93 India nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 94 India nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 95 Australia nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 96 Australia nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 97 Australia nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 98 Australia nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 99 Rest of Asia pacific nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 100 Rest of Asia pacific nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 101 Rest of Asia Pacific nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 102 Rest of Asia Pacific nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 103 Latin America nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 104 Latin America nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 105 Latin America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 106 Latin America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 107 Latin America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 108 Latin America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 109 Brazil nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 110 Brazil nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 111 Brazil nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 112 Brazil nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 113 Mexico nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 114 Mexico nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 115 Mexico nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 116 Mexico nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 117 Argentina nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 118 Argentina nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 119 Argentina nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 120 Argentina nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 121 Rest of Latin America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 122 Rest of Latin America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 123 Rest of Latin America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 124 Rest of Latin America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 125 Middle East & Africa nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 126 Middle East & Africa nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 127 Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 128 Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 129 Middle East & Africa nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 130 Middle East & Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 131 South Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 132 South Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 133 South Africa nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 134 South Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 135 Saudi Arabia nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 136 Saudi Arabia nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 137 Saudi Arabia nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 138 Saudi Arabia nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 139 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 140 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 141 Rest of Middle East & Africa nanotechnology-based drug delivery market size, application, 2018-2022 (USD Million)
• TABLE 142 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Nanotechnology-based drug delivery industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by technology
• FIG 8 Growth potential analysis, by application
• FIG 9 Porter's analysis
• FIG 10 PESTEL analysis
• FIG 11 Company matrix analysis, 2022
• FIG 12 Competitive analysis of major market players, 2022
• FIG 13 Competitive positioning matrix
• FIG 14 Strategic dashboard, 2022